Table 1 Patients excluded from MRgFUS treatment due to the possibility of underlying malignancy.
From: MRI pelvis screening to guide treatment of pelvic pathology
Reason for Suspected Malignancy | Number of Patients |
|---|---|
Heterogeneous enhancement with ill-defined areas of hypo-enhancement | 3 |
Overcall | 3 |
Intra-cavitary mass w/blood products and heterogeneous enhancement | 2 |
Intra-cavitary masswith homogenous enhancement | 2 |
Ill-defined borders | 1 |
Heterogeneous enhancement with well-defined hypo-enhancement | 1 |